In addition, the blood eosinophil phenotype in COVID-19 did not correspond either to a tissue eosinophil phenotype, such as in allergic asthma where activated airway eosinophils displayed a very low amount of surface CD125 and high amounts of CD44 [28]. The gene discussed is CD44; the disease is allergic asthma.